CPDA-1 - Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) Solution
Navigation: NDC > Supplier starting with: F > FENWAL, INC.| Field | Value |
|---|---|
| NDC Code: | 0942-9394 |
| Proprietary Name: | CPDA-1 |
| Suffix: | |
| Non-Proprietary Name: | Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) Solution |
| Dosage Form: | SOLUTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 01-03-2007 |
| Category Name: | NDA |
| Application Number: | BN077420 |
| Labeler: | FENWAL, INC. |
| Substance Name: | ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
| Active Numerator Strength: | 17.3; 188; 2; 140; 1.66 |
| Active Ingredient Unit: | mg/63mL; mg/63mL; g/63mL; mg/63mL; g/63mL |
| Pharm Classes: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| DEA Schedule: |